Fatemi Nasrin, Dusick Joshua R, de Paiva Neto Manoel A, Kelly Daniel F
Brain Tumor Center, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California 90404, USA.
Neurosurgery. 2008 Oct;63(4 Suppl 2):244-56; discussion 256. doi: 10.1227/01.NEU.0000327025.03975.BA.
THE DIRECT ENDONASAL transsphenoidal approach to the sella with the operating microscope was initially described more than 20 years ago. Herein, we describe the technique, its evolution, and lessons learned over a 10-year period for treating pituitary adenomas and other parasellar pathology. From July 1998 to January 2008, 812 patients underwent a total of 881 operations for a pituitary adenoma (n = 605), Rathke's cleft cyst (n = 59), craniopharyngioma (n = 26), parasellar meningioma (n = 23), chordoma (n = 18), or other pathological condition (n = 81). Of these, 118 operations (13%) included an extended approach to the suprasellar, infrasellar/clival, or cavernous sinus regions. Endoscopic assistance was used in 163 cases (19%) overall, including 36% of the last 200 cases in the series and 18 (72%) of the last 25 extended endonasal cases. Surgical complications included 19 postoperative cerebrospinal fluid leaks (2%), 6 postoperative hematomas (0.7%), 4 carotid artery injuries (0.4%), 4 new permanent neurological deficits (0.4%), 3 cases of bacterial meningitis (0.3%), and 2 deaths (0.2%). The overall complication rate was higher in the first 500 cases in the series and in extended approach cases. Major technical modifications over the 10-year period included increased use of shorter (60-70 mm) endonasal speculums for greater instrument maneuverability and visualization, the micro-Doppler probe for cavernous carotid artery localization, endoscopy for more panoramic visualization, and a graded cerebrospinal fluid leak repair protocol. These changes appear to have collectively and incrementally made the approach safer and more effective. In summary, the endonasal approach provides a minimally invasive route for removal of pituitary adenomas and other parasellar tumors.
经鼻蝶窦直接入路结合手术显微镜治疗鞍区病变最初是在20多年前被描述的。在此,我们描述该技术、其演变过程以及在10年期间治疗垂体腺瘤和其他鞍旁病变所获得的经验教训。1998年7月至2008年1月,812例患者因垂体腺瘤(n = 605)、拉克氏囊肿(n = 59)、颅咽管瘤(n = 26)、鞍旁脑膜瘤(n = 23)、脊索瘤(n = 18)或其他病理状况(n = 81)共接受了881次手术。其中,118次手术(13%)包括向鞍上、鞍下/斜坡或海绵窦区域的扩大入路。总体上163例(19%)使用了内镜辅助,包括该系列最后200例中的36%以及最后25例扩大经鼻入路中的18例(72%)。手术并发症包括19例术后脑脊液漏(2%)、6例术后血肿(0.7%)、4例颈动脉损伤(0.4%)、4例新的永久性神经功能缺损(0.4%)、3例细菌性脑膜炎(0.3%)和2例死亡(0.2%)。该系列前500例手术以及扩大入路手术的总体并发症发生率更高。10年期间的主要技术改进包括更多地使用较短(60 - 70毫米)的鼻内镜以提高器械的可操作性和视野,使用微型多普勒探头定位海绵窦段颈动脉,使用内镜获得更全景的视野,以及采用分级脑脊液漏修补方案。这些改变似乎共同且逐步地使该入路更安全、更有效。总之,经鼻入路为切除垂体腺瘤和其他鞍旁肿瘤提供了一条微创途径。